Clinical Trial

SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)

Name: SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031) — clinical trial record (NCT07680530)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The primary purpose of the clinical investigation is to verify the SpO2 accuracy of the Philips AlarX5 SpO2 sensor with Nellcor OxiMax SpO2 Board.

Protocol Amendment History 1 change

critical Trial completed 2026-07-17

Trial Details

NCT Number	NCT07680530
Lead Sponsor	Philips Clinical & Medical Affairs Global
Conditions	Pulse Oximetry
Enrollment	43 participants
Start Date	2026-05-28
Primary Completion	2026-06-29 (estimated)
Study Completion	2026-06-29 (estimated)
Updated on ClinicalTrials.gov	2026-07-16